Genome-wide association studies (GWAS), as well as the identification of de novo variants in the CACNA1I gene, have contributed to implicate CACNA1I as a genetic risk factor in schizophrenia (SCZ) [64, 77, 129]. The gene discussed is CACNA1I; the disease is schizophrenia.